Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 323.24M | P/E | - | EPS this Y | 51.80% | Ern Qtrly Grth | - |
| Income | -1.44B | Forward P/E | -1.07 | EPS next Y | -6.60% | 50D Avg Chg | 2.00% |
| Sales | 481.58M | PEG | 0.00 | EPS past 5Y | - | 200D Avg Chg | -31.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | 8.00% | 52W High Chg | -86.00% |
| Recommedations | 3.50 | Quick Ratio | 2.14 | Shares Outstanding | 286.49M | 52W Low Chg | 22.00% |
| Insider Own | 1.51% | ROA | -23.70% | Shares Float | 284.38M | Beta | 1.59 |
| Inst Own | 47.96% | ROE | - | Shares Shorted/Prior | 67.76M/59.35M | Price | 1.24 |
| Gross Margin | 27.13% | Profit Margin | -299.14% | Avg. Volume | 7,944,709 | Target Price | 0.53 |
| Oper. Margin | -84.87% | Earnings Date | Feb 26 | Volume | 6,620,427 | Change | -6.06% |
About Invitae Corporation
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. On February 13, 2024, Invitae Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Jersey.
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Nussbaum Robert L | Chief Medical Office.. Chief Medical Officer | Jun 13 | Sell | 1.3770 | 7,086 | 9,757 | 569,345 | 06/15/23 |
| Wen Yafei | Chief Financial Offi.. Chief Financial Officer | May 16 | Sell | 1.1993 | 43,452 | 52,112 | 700,297 | 05/24/23 |
| George Sean E | Director Director | Dec 16 | Sell | 2.06 | 55,979 | 115,317 | 732,677 | 12/20/22 |
| Brida Thomas | See remarks See remarks | Aug 16 | Sell | 4.5503 | 7,048 | 32,071 | 386,267 | 08/18/22 |
| Nussbaum Robert L | Chief Medical Office.. Chief Medical Officer | Aug 16 | Sell | 4.5503 | 7,048 | 32,071 | 396,532 | 08/18/22 |
| WERNER ROBERT F. | Chief Accounting Off.. Chief Accounting Officer | May 17 | Sell | 3.61 | 10,102 | 36,468 | 201,909 | 05/19/22 |
| Knight Kenneth D. | Chief Operating Offi.. Chief Operating Officer | May 17 | Sell | 3.8101 | 28,295 | 107,807 | 518,895 | 05/19/22 |
| Brida Thomas | See Remarks See Remarks | May 17 | Sell | 3.8101 | 6,098 | 23,234 | 393,315 | 05/19/22 |
| George Sean E | President & CEO President & CEO | May 17 | Sell | 3.8101 | 18,296 | 69,710 | 794,691 | 05/19/22 |
| Wen Yafei | Chief Financial Offi.. Chief Financial Officer | May 17 | Sell | 3.8101 | 17,042 | 64,932 | 344,374 | 05/19/22 |
| Nussbaum Robert L | Chief Medical Office.. Chief Medical Officer | May 17 | Sell | 3.8101 | 6,098 | 23,234 | 403,580 | 05/19/22 |
| George Sean E | President & CEO President & CEO | Mar 12 | Sell | 6.69 | 31,389 | 209,992 | 812,987 | 03/16/22 |
| Brida Thomas | General Counsel General Counsel | Mar 12 | Sell | 6.69 | 17,987 | 120,333 | 229,739 | 03/16/22 |
| Wen Yafei | Chief Financial Offi.. Chief Financial Officer | Mar 12 | Sell | 6.69 | 3,289 | 22,003 | 136,416 | 03/16/22 |
| Nussbaum Robert L | Chief Medical Office.. Chief Medical Officer | Mar 12 | Sell | 6.69 | 19,588 | 131,044 | 241,167 | 03/16/22 |
| Stueland Katherine | Chief Commercial Off.. Chief Commercial Officer | Jun 16 | Sell | 31.6 | 20,340 | 642,744 | 214,231 | 06/16/21 |
| George Sean E | President & CEO President & CEO | Apr 23 | Sell | 36.55 | 3,675 | 134,321 | 669,920 | 04/23/21 |
| Stueland Katherine | Chief Commercial Off.. Chief Commercial Officer | Apr 15 | Sell | 40.26 | 19,893 | 800,892 | 189,871 | 04/15/21 |
| George Sean E | President & CEO President & CEO | Mar 05 | Sell | 37.62 | 3,675 | 138,254 | 633,668 | 03/05/21 |
| Brida Thomas | General Counsel General Counsel | Mar 03 | Sell | 42.93 | 5,000 | 214,650 | 202,876 | 03/03/21 |
| George Sean E | President & CEO President & CEO | Jan 22 | Option | 8.7 | 5,000 | 43,500 | 646,018 | 01/22/21 |
| George Sean E | President & CEO President & CEO | Jan 22 | Sell | 54.52 | 8,675 | 472,961 | 637,343 | 01/22/21 |
| Stueland Katherine | Chief Commercial Off.. Chief Commercial Officer | Jan 15 | Option | 10.94 | 4,199 | 45,937 | 207,251 | 01/15/21 |
| Stueland Katherine | Chief Commercial Off.. Chief Commercial Officer | Jan 15 | Sell | 51.17 | 4,199 | 214,863 | 203,052 | 01/15/21 |
| Myers Jason W. | Director Director | Dec 28 | Sell | 50.65 | 174,152 | 8,820,799 | 410,597 | 12/28/20 |
| Myers Jason W. | Director Director | Dec 23 | Sell | 50.77 | 224,965 | 11,421,473 | 584,749 | 12/23/20 |
| George Sean E | President & CEO President & CEO | Dec 23 | Sell | 52.85 | 3,675 | 194,224 | 631,018 | 12/23/20 |
| Myers Jason W. | Director Director | Dec 18 | Sell | 47.69 | 253,912 | 12,109,063 | 809,714 | 12/18/20 |
| AGUIAR ERIC | Director Director | Dec 18 | Option | 24.16 | 10,000 | 241,600 | 10,000 | 12/18/20 |
| AGUIAR ERIC | Director Director | Dec 18 | Sell | 51.1 | 10,000 | 511,000 | 12/18/20 | |
| Stueland Katherine | Chief Commercial Off.. Chief Commercial Officer | Dec 16 | Sell | 57.97 | 34,300 | 1,988,371 | 203,052 | 12/16/20 |
| WERNER ROBERT F. | Chief Accounting Off.. Chief Accounting Officer | Nov 27 | Sell | 49.59 | 2,427 | 120,355 | 58,398 | 11/27/20 |
| Guyer Shelly D | Chief Financial Offi.. Chief Financial Officer | Nov 20 | Sell | 47.09 | 3,000 | 141,270 | 224,520 | 11/20/20 |
| Brida Thomas | General Counsel General Counsel | Nov 18 | Sell | 46.17 | 5,000 | 230,850 | 207,876 | 11/18/20 |
| AGUIAR ERIC | Director Director | Nov 18 | Option | 9.61 | 30,000 | 288,300 | 30,000 | 11/18/20 |
| AGUIAR ERIC | Director Director | Nov 18 | Sell | 46.71 | 30,000 | 1,401,300 | 11/18/20 |